Company Overview
Snapshot
Founded in June 2024, VI Biotherapeutics operates with 1–10 employees. The company has secured funding across two rounds, including a grant from the Israel Innovation Authority in January 2025.
Business overview
VI Biotherapeutics is a stealth-mode company operating within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology. While details about its core product or technology remain undisclosed, the company is engaged in research and development, indicating an early-stage focus on therapeutic innovations.
Log in to access full profile ›Company Intelligence Q&A
- When was VI Biotherapeutics founded?
- VI Biotherapeutics was founded in June 2024.
- What is VI Biotherapeutics' primary sector?
- VI Biotherapeutics operates in the Health Tech & Life Sciences sector, with a specific focus on Pharma & Medical Biotechnology.
- What is the current employee count for VI Biotherapeutics?
- VI Biotherapeutics currently has 1–10 employees.
- Has VI Biotherapeutics received any grants?
- In January 2025, VI Biotherapeutics secured a grant from the Israel Innovation Authority.
- What is the current product stage of VI Biotherapeutics?
- VI Biotherapeutics is currently in the R&D product stage, focusing on therapeutic innovations within the Pharma & Medical Biotechnology sector.